Annals
Established in 1927 by the American College of Physicians
:
Advanced search
 
box Article
 arrow  Table of Contents                
space
 arrow  Full Text of this article Free
space
 arrow  Figures/Tables List
space
box Services
 arrow  Send comment/rapid response letter
space
 arrow  Notify a friend about this article
space
 arrow  Alert me when this article is cited
space
 arrow  Add to Personal Archive
space
 arrow  Download to Citation Manager
space
 arrow  ACP Search                        
space
 arrow  Get Permissions
space
box Google Scholar
 arrow  Search for Related Content
space
box PubMed
Articles in PubMed by Author:
  arrow  Lips, P.
space
  arrow  Bouter, L. M.
space
 arrow  Related Articles in PubMed
space
 arrow  PubMed Citation
space
 arrow  PubMed
space

ARTICLE

Vitamin D Supplementation and Fracture Incidence in Elderly Persons

A Randomized, Placebo-Controlled Clinical Trial

right arrow Paul Lips, MD; Wilco C. Graafmans, MS; Marcel E. Ooms, MD; P. Dick Bezemer, PhD; and Lex M. Bouter, PhD

15 February 1996 | Volume 124 Issue 4 | Pages 400-406

Objective: To determine whether vitamin D supplementation decreases the incidence of hip fractures and other peripheral bone fractures.

Design: Prospective, double-blind trial.

Setting: Community setting (Amsterdam and surrounding area).

Patients: 2578 persons (1916 women, 662 men) 70 years of age and older (mean age ±SD, 80 ± 6 years) living independently, in apartments for elderly persons, or in homes for elderly persons.

Intervention: Participants were randomly assigned to receive either vitamin D3, 400 IU in one tablet daily, or placebo for a maximum of 3.5 years.

Measurements: Dietary calcium intake and serum 25-hydroxyvitamin D [25(OH)D] were estimated in a subset of participants. During follow-up, attention was concentrated on hip fractures and other peripheral fractures. The maximal follow-up period was 4 years. The results were evaluated by survival analysis.

Results: Mean dietary calcium intake from dairy products was 868 mg/d. Mean serum 25(OH)D concentration in the third year of the study was 23 nmol/L in the placebo group and 60 nmol/L in the vitamin D group. Median follow-up was 3.5 years, and total follow-up was 8450 patient-years. During follow-up, 306 persons in the placebo group and 282 persons in the vitamin D group died (P = 0.20). Hip fractures occurred in 48 persons in the placebo group and 58 persons in the vitamin D group (P = 0.39, intention-to-treat analysis). Other peripheral fractures occurred in 74 persons in the placebo group and 77 persons in the vitamin D group (P = 0.86).

Conclusion: Our results do not show a decrease in the incidence of hip fractures and other peripheral fractures in Dutch elderly persons after vitamin D supplementation.

Author and Article Information
space

From Vrije Universiteit, Amsterdam, the Netherlands.
Acknowledgments: The authors thank the many persons who contributed to this study, especially Mrs. Nel van der Kreeke, Els Lommerse-Rusman, Saskia van Bennekom, Madeleine de Boer, and Andries Tahapary for invaluable organizational help; Drs. Ronald ter Schegget, Didy Kriegsman, and Nico de Neeling for their help in the start-up phase of the study; Dr. Wim J. van der Vijgh and Simon Velt for the measurement of 25-hydroxyvitamin D; Hans Wagemaker for the randomization of the tablets; Dr. W. Ezechiels and other general practitioners for their help; staff and personnel of the participating homes for the elderly for their assistance; and Drs. Olli Miettinen and Hans Valkenburg for advice in designing the study.
Grant Support: In part by the Praeventiefonds, the Hague, the Netherlands (grant 28-1112-1). Vitamin D and placebo tablets were provided by Solvay-Duphar, Inc., Weesp, the Netherlands.
Requests for Reprints: Paul Lips, MD, Department of Endocrinology, Academisch Ziekenhuis Vrije Universiteit, PO Box 7057, 1007 MB Amsterdam, the Netherlands.
Current Author Addresses: Dr. Lips: Department of Endocrinology, Academisch Ziekenhuis Vrije Universiteit, PO Box 7057, 1007 MB Amsterdam, the Netherlands.




This article has been cited by other articles:


Home page
Am. J. Clin. Nutr.Home page
C. J. Lamberg-Allardt and H. T Viljakainen
25-Hydroxyvitamin D and functional outcomes in adolescents
Am. J. Clinical Nutrition, August 1, 2008; 88(2): 534S - 536S.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
B. Dawson-Hughes
Serum 25-hydroxyvitamin D and functional outcomes in the elderly
Am. J. Clinical Nutrition, August 1, 2008; 88(2): 537S - 540S.
[Abstract] [Full Text] [PDF]


Home page
JNCI J Natl Cancer InstHome page
L. A. Mucci and D. Spiegelman
Vitamin D and Prostate Cancer Risk--A Less Sunny Outlook?
J Natl Cancer Inst, June 4, 2008; 100(11): 759 - 761.
[Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
H. A Bischoff-Ferrari, J. R Rees, M. V Grau, E. Barry, J. Gui, and J. A Baron
Effect of calcium supplementation on fracture risk: a double-blind randomized controlled trial
Am. J. Clinical Nutrition, June 1, 2008; 87(6): 1945 - 1951.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
S. Khosla, S. Amin, and E. Orwoll
Osteoporosis in Men
Endocr. Rev., June 1, 2008; 29(4): 441 - 464.
[Abstract] [Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
H. Smith, F. Anderson, H. Raphael, P. Maslin, S. Crozier, and C. Cooper
Effect of annual intramuscular vitamin D on fracture risk in elderly men and women a population-based, randomized, double-blind, placebo-controlled trial
Rheumatology, December 1, 2007; 46(12): 1852 - 1857.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
P. Autier and S. Gandini
Vitamin D Supplementation and Total Mortality: A Meta-analysis of Randomized Controlled Trials
Arch Intern Med, September 10, 2007; 167(16): 1730 - 1737.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Boonen, P. Lips, R. Bouillon, H. A. Bischoff-Ferrari, D. Vanderschueren, and P. Haentjens
Need for Additional Calcium to Reduce the Risk of Hip Fracture with Vitamin D Supplementation: Evidence from a Comparative Metaanalysis of Randomized Controlled Trials
J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1415 - 1423.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
C. Jackson, S. Gaugris, S.S. Sen, and D. Hosking
The effect of cholecalciferol (vitamin D3) on the risk of fall and fracture: a meta-analysis
QJM, April 1, 2007; 100(4): 185 - 192.
[Abstract] [Full Text] [PDF]


Home page
Age AgeingHome page
M. Law, H. Withers, J. Morris, and F. Anderson
Vitamin D supplementation and the prevention of fractures and falls: results of a randomised trial in elderly people in residential accommodation
Age Ageing, September 1, 2006; 35(5): 482 - 486.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
H. A Bischoff-Ferrari, E. Giovannucci, W. C Willett, T. Dietrich, and B. Dawson-Hughes
Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes
Am. J. Clinical Nutrition, July 1, 2006; 84(1): 18 - 28.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Coll. Nutr.Home page
D. Bunout, G. Barrera, L. Leiva, V. Gattas, M. P. de la Maza, F. Haschke, P. Steenhout, P. Klassen, C. Hager, E. Offord, et al.
Effect of a Nutritional Supplementation on Bone Health in Chilean Elderly Subjects with Femoral Osteoporosis
J. Am. Coll. Nutr., June 1, 2006; 25(3): 170 - 177.
[Abstract] [Full Text] [PDF]


Home page
QJMHome page
R.M. Francis, F.H. Anderson, S. Patel, O. Sahota, and T.P. van Staa
Calcium and vitamin D in the prevention of osteoporotic fractures
QJM, June 1, 2006; 99(6): 355 - 363.
[Full Text] [PDF]


Home page
Am J Health Syst PharmHome page
L. B. Michaud and S. Goodin
Cancer-treatment-induced bone loss, part 2
Am. J. Health Syst. Pharm., March 15, 2006; 63(6): 534 - 546.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
R. D. Jackson, A. Z. LaCroix, M. Gass, R. B. Wallace, J. Robbins, C. E. Lewis, T. Bassford, S. A.A. Beresford, H. R. Black, P. Blanchette, et al.
Calcium plus Vitamin D Supplementation and the Risk of Fractures
N. Engl. J. Med., February 16, 2006; 354(7): 669 - 683.
[Abstract] [Full Text] [PDF]


Home page
Age AgeingHome page
T. J. Allain
Vitamin D and fracture prevention--treatment still indicated but clarification needed
Age Ageing, November 1, 2005; 34(6): 542 - 544.
[Full Text] [PDF]


Home page
J Bone Joint Surg BrHome page
M. K. Karlsson, P. Gerdhem, and H. G. Ahlborg
The prevention of osteoporotic fractures
J Bone Joint Surg Br, October 1, 2005; 87-B(10): 1320 - 1327.
[Full Text] [PDF]


Home page
Arch Intern MedHome page
J. F. Aloia, S. A. Talwar, S. Pollack, and J. Yeh
A Randomized Controlled Trial of Vitamin D3 Supplementation in African American Women
Arch Intern Med, July 25, 2005; 165(14): 1618 - 1623.
[Abstract] [Full Text] [PDF]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
S. L. Greenspan, N. M. Resnick, and R. A. Parker
Vitamin D Supplementation in Older Women
J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2005; 60(6): 754 - 759.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
H. A. Bischoff-Ferrari, W. C. Willett, J. B. Wong, E. Giovannucci, T. Dietrich, and B. Dawson-Hughes
Fracture Prevention With Vitamin D Supplementation: A Meta-analysis of Randomized Controlled Trials
JAMA, May 11, 2005; 293(18): 2257 - 2264.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
J. W Nieves
Osteoporosis: the role of micronutrients
Am. J. Clinical Nutrition, May 1, 2005; 81(5): 1232S - 1239S.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
J. Porthouse, S. Cockayne, C. King, L. Saxon, E. Steele, T. Aspray, M. Baverstock, Y. Birks, J. Dumville, R. Francis, et al.
Randomised controlled trial of calcium and supplementation with cholecalciferol (vitamin D3) for prevention of fractures in primary care
BMJ, April 30, 2005; 330(7498): 1003.
[Abstract] [Full Text] [PDF]


Home page
IBMS BoneKEyHome page
B. Dawson-Hughes
The Role of Vitamin D in Fracture Prevention
IBMS BoneKEy, April 1, 2005; 2(4): 6 - 10.
[Full Text] [PDF]


Home page
BMJHome page
G. Venning
Recent developments in vitamin D deficiency and muscle weakness among elderly people
BMJ, March 5, 2005; 330(7490): 524 - 526.
[Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
M. S Calvo, S. J Whiting, and C. N Barton
Vitamin D fortification in the United States and Canada: current status and data needs
Am. J. Clinical Nutrition, December 1, 2004; 80(6): 1710S - 1716S.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
B. Dawson-Hughes
Racial/ethnic considerations in making recommendations for vitamin D for adult and elderly men and women
Am. J. Clinical Nutrition, December 1, 2004; 80(6): 1763S - 1766S.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
H. A. Bischoff-Ferrari, B. Dawson-Hughes, W. C. Willett, H. B. Staehelin, M. G. Bazemore, R. Y. Zee, and J. B. Wong
Effect of Vitamin D on Falls: A Meta-analysis
JAMA, April 28, 2004; 291(16): 1999 - 2006.
[Abstract] [Full Text] [PDF]


Home page
Evid. Based Nurs.Home page
D. Forbes
Oral vitamin D3 supplementation reduced fractures in community dwelling elderly people
Evid. Based Nurs., October 1, 2003; 6(4): 113 - 113.
[Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
L. Cooper, P. B Clifton-Bligh, M L. Nery, G. Figtree, S. Twigg, E. Hibbert, and B. G Robinson
Vitamin D supplementation and bone mineral density in early postmenopausal women
Am. J. Clinical Nutrition, May 1, 2003; 77(5): 1324 - 1329.
[Abstract] [Full Text] [PDF]


Home page
The Annals of PharmacotherapyHome page
S. F Eichner, K. B Lloyd, and E. M Timpe
Comparing Therapies for Postmenopausal Osteoporosis Prevention and Treatment
Ann. Pharmacother., May 1, 2003; 37(5): 711 - 724.
[Abstract] [Full Text] [PDF]


Home page
BMJHome page
D. P Trivedi, R. Doll, and K. T. Khaw
Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial
BMJ, March 1, 2003; 326(7387): 469 - 469.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
D. Feskanich, W. C Willett, and G. A Colditz
Calcium, vitamin D, milk consumption, and hip fractures: a prospective study among postmenopausal women
Am. J. Clinical Nutrition, February 1, 2003; 77(2): 504 - 511.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
S P Tuck and R M Francis
Osteoporosis
Postgrad. Med. J., September 1, 2002; 78(923): 526 - 532.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
E. Papadimitropoulos, G. Wells, B. Shea, W. Gillespie, B. Weaver, N. Zytaruk, A. Cranney, J. Adachi, P. Tugwell, R. Josse, et al.
VIII: Meta-Analysis of the Efficacy of Vitamin D Treatment in Preventing Osteoporosis in Postmenopausal Women
Endocr. Rev., August 1, 2002; 23(4): 560 - 569.
[Full Text] [PDF]


Home page
JAMAHome page
K. M. Fairfield and R. H. Fletcher
Vitamins for Chronic Disease Prevention in Adults: Scientific Review
JAMA, June 19, 2002; 287(23): 3116 - 3126.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
B. L. Riggs, S. Khosla, and L. J. Melton III
Sex Steroids and the Construction and Conservation of the Adult Skeleton
Endocr. Rev., June 1, 2002; 23(3): 279 - 302.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
R. Marcus, M. Wong, H. Heath III, and J. L. Stock
Antiresorptive Treatment of Postmenopausal Osteoporosis: Comparison of Study Designs and Outcomes in Large Clinical Trials with Fracture as an Endpoint
Endocr. Rev., February 1, 2002; 23(1): 16 - 37.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
W. C. Willett and M. J. Stampfer
What Vitamins Should I Be Taking, Doctor?
N. Engl. J. Med., December 20, 2001; 345(25): 1819 - 1824.
[Full Text] [PDF]


Home page
QJMHome page
R. Eastell, D.M. Reid, J. Compston, C. Cooper, I. Fogelman, R.M. Francis, S.M. Hay, D.J. Hosking, D.W. Purdie, S.H. Ralston, et al.
Secondary prevention of osteoporosis: when should a non-vertebral fracture be a trigger for action?
QJM, November 1, 2001; 94(11): 575 - 597.
[Abstract] [Full Text] [PDF]


Home page
ANN INTERN MEDHome page
J. M. Grossman and C. H. MacLean
Quality Indicators for the Management of Osteoporosis in Vulnerable Elders
Ann Intern Med, October 16, 2001; 135(8_Part_2): 722 - 730.
[Full Text] [PDF]


Home page
Endocr. Rev.Home page
P. Lips
Vitamin D Deficiency and Secondary Hyperparathyroidism in the Elderly: Consequences for Bone Loss and Fractures and Therapeutic Implications
Endocr. Rev., August 1, 2001; 22(4): 477 - 501.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
J. C. Gallagher, S. E. Fowler, J. R. Detter, and S. S. Sherman
Combination Treatment with Estrogen and Calcitriol in the Prevention of Age-Related Bone Loss
J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3618 - 3628.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
R. M. Neer, C. D. Arnaud, J. R. Zanchetta, R. Prince, G. A. Gaich, J.-Y. Reginster, A. B. Hodsman, E. F. Eriksen, S. Ish-Shalom, H. K. Genant, et al.
Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis
N. Engl. J. Med., May 10, 2001; 344(19): 1434 - 1441.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. Lips, T. Duong, A. Oleksik, D. Black, S. Cummings, D. Cox, and T. Nickelsen
A Global Study of Vitamin D Status and Parathyroid Function in Postmenopausal Women with Osteoporosis: Baseline Data from the Multiple Outcomes of Raloxifene Evaluation Clinical Trial
J. Clin. Endocrinol. Metab., March 1, 2001; 86(3): 1212 - 1221.
[Abstract] [Full Text]


Home page
QJMHome page
D.M. Reid and H.M. Macdonald
Nutrition and bone: is there more to it than just calcium and vitamin D?
QJM, February 1, 2001; 94(2): 53 - 56.
[Full Text] [PDF]


Home page
Rheumatology (Oxford)Home page
J. E. Compston
Pharmacological interventions for post-menopausal osteoporosis: an evidence-based approach
Rheumatology, December 1, 2000; 39(12): 1309 - 1312.
[Full Text] [PDF]


Home page
FASEB J.Home page
E. M. GARDINER, P. A. BALDOCK, G. P. THOMAS, N. A. SIMS, N. K. HENDERSON, B. HOLLIS, C. P. WHITE, K. L. SUNN, N. A. MORRISON, W. R. WALSH, et al.
Increased formation and decreased resorption of bone in mice with elevated vitamin D receptor in mature cells of the osteoblastic lineage
FASEB J, October 1, 2000; 14(13): 1908 - 1916.
[Abstract] [Full Text]


Home page
J. Gerontol. A Biol. Sci. Med. Sci.Home page
H. M. Perry III
Editorial: Facets of Femoral Fracture
J. Gerontol. A Biol. Sci. Med. Sci., September 1, 2000; 55(9): 487M - 488.
[Full Text]


Home page
QJMHome page
R.M. Francis, S.P. Baillie, A.J. Chuck, P.R. Crook, T. Daymond, N. Dunn, J.N. Fordham, C. Kelly, and A. Rodgers
Management of osteoporosis in patients with hip fractures
QJM, August 1, 2000; 93(8): 501 - 506.
[Full Text] [PDF]


Home page
ANN INTERN MEDHome page
K. E. Ensrud, T. Duong, J. A. Cauley, R. P. Heaney, R. L. Wolf, E. Harris, S. R. Cummings, and for the Study of Osteoporotic Fractures Research G
Low Fractional Calcium Absorption Increases the Risk for Hip Fracture in Women with Low Calcium Intake
Ann Intern Med, March 7, 2000; 132(5): 345 - 353.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
S. T. Harris, N. B. Watts, H. K. Genant, C. D. McKeever, T. Hangartner, M. Keller, C. H. Chesnut III, J. Brown, E. F. Eriksen, M. S. Hoseyni, et al.
Effects of Risedronate Treatment on Vertebral and Nonvertebral Fractures in Women With Postmenopausal Osteoporosis: A Randomized Controlled Trial
JAMA, October 13, 1999; 282(14): 1344 - 1352.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
H. M. Perry III
The Endocrinology of Aging
Clin. Chem., August 1, 1999; 45(8): 1369 - 1376.
[Abstract] [Full Text] [PDF]


Home page
TraumaHome page
F. Anderson and C Cooper
The influence of osteoporosis in trauma
Trauma, July 1, 1999; 1(3): 181 - 192.
[Abstract] [PDF]


Home page
Am. J. Clin. Nutr.Home page
R. Vieth
Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety
Am. J. Clinical Nutrition, May 1, 1999; 69(5): 842 - 856.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Komulainen, H. Kröger, M. T. Tuppurainen, A.-M. Heikkinen, E. Alhava, R. Honkanen, J. Jurvelin, and S. Saarikoski
Prevention of Femoral and Lumbar Bone Loss with Hormone Replacement Therapy and Vitamin D3 in Early Postmenopausal Women: A Population-Based 5-Year Randomized Trial
J. Clin. Endocrinol. Metab., February 1, 1999; 84(2): 546 - 552.
[Abstract] [Full Text]


Home page
BMJHome page
J E Compston
Vitamin D deficiency: time for action
BMJ, November 28, 1998; 317(7171): 1466 - 1467.
[Full Text]


Home page
J. Clin. Endocrinol. Metab.Home page
D. Storm, R. E. E. S. Porter, K. Musgrave, D. Vereault, C. Patton, C. Kessenich, S. Mohan, T. Chen, M. F. Holick, and C. J. Rosen
Calcium Supplementation Prevents Seasonal Bone Loss and Changes in Biochemical Markers of Bone Turnover in Elderly New England Women: A Randomized Placebo-Controlled Trial
J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 3817 - 3825.
[Abstract] [Full Text]


Home page
Ann Rheum DisHome page
T Masud, B Mulcahy, A V Thompson, S Donnelly, R W Keen, D V Doyle, and T D Spector
Effects of cyclical etidronate combined with calcitriol versus cyclical etidronate alone on spine and femoral neck bone mineral density in postmenopausal osteoporotic women
Ann Rheum Dis, June 1, 1998; 57(6): 346 - 349.
[Abstract] [Full Text]


Home page
NEJMHome page
M. K. Thomas, D. M. Lloyd-Jones, R. I. Thadhani, A. C. Shaw, D. J. Deraska, B. T. Kitch, E. C. Vamvakas, I. M. Dick, R. L. Prince, and J. S. Finkelstein
Hypovitaminosis D in Medical Inpatients
N. Engl. J. Med., March 19, 1998; 338(12): 777 - 783.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
R. Eastell
Treatment of Postmenopausal Osteoporosis
N. Engl. J. Med., March 12, 1998; 338(11): 736 - 746.
[Full Text] [PDF]